Talkmed logo

5G3 - Talkmed Share Price

S$0.505 0.0  0.0%

Last Trade - 23/01/20

Sector
Healthcare
Size
Mid Cap
Market Cap £374.7m
Enterprise Value £335.0m
Revenue £41.1m
Position in Universe 1310th / 5985
Bullish
Bearish
Unlock 5G3 Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

5G3 Revenue Unlock 5G3 Revenue

Net Income

5G3 Net Income Unlock 5G3 Revenue

Normalised EPS

5G3 Normalised EPS Unlock 5G3 Revenue

PE Ratio Range

5G3 PE Ratio Range Unlock 5G3 Revenue

Dividend Yield Range

5G3 Dividend Yield Range Unlock 5G3 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
5G3 EPS Forecasts Unlock 5G3 Revenue
Profile Summary

TalkMed Group Limited is a Singapore-based investment holding company. The Company's principal activities are the provision of medical oncology services and stem cell transplant services. The Company's segments include Oncology services and Stem cells services. Its doctors provide tertiary healthcare services in the fields of medical oncology, stem cell transplant and palliative care to the oncology patients in the private sector in Singapore through Parkway Cancer Centre (PCC). Its clinical functions include attending to patients, examination and administering medical treatment to patients and performing minor outpatient surgical procedures, prescribing medicines and investigations, such as laboratory tests or diagnostic procedures. These clinical functions also include the review of investigation results and follow-up care with the patient. It provides medical oncology services and palliative care services with approximately 13 doctors at over eight clinics.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated September 10, 2013
Public Since January 30, 2014
No. of Shareholders: 952
No. of Employees: 53
Sector Healthcare
Industry Healthcare Providers & Services
Index
Exchange Singapore Exchange Securities Trading Ltd
Shares in Issue 1,314,501,723
Free Float (0.0%)
Eligible for
ISAs
SIPPs
5G3 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 5G3
Upcoming Events for 5G3
Friday 24th April, 2020 Estimate
Talkmed Group Ltd Annual Shareholders Meeting
Similar to 5G3
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.